Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

<b><i>Background:</i></b> The Cilostazol Stroke Prevention Study 2 (CSPS 2) showed that cilostazol significantly reduced the risk of stroke by 25.7% relative to aspirin, with significantly fewer hemorrhagic events, in patients with prior ischem...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Shinichiro Uchiyama, Yukito Shinohara, Yasuo Katayama, Takenori Yamaguchi, Shunnosuke Handa, Kempei Matsuoka, Yasuo Ohashi, Norio Tanahashi, Hiroko Yamamoto, Chokoh Genka, Yasuhisa Kitagawa, Hideo Kusuoka, K Nishimaru, Motoo Tsushima, Yukihiro Koretsune, Tohru Sawada, Chikuma Hamada
Materiálatiipa: Artigo
Giella:eaŋgalasgiella
Almmustuhtton: 2014
Liŋkkat:https://doi.org/10.1159/000360811
https://karger.com/ced/article-pdf/37/4/296/2351895/000360811.pdf
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

https://doi.org/10.1159/000360811
https://karger.com/ced/article-pdf/37/4/296/2351895/000360811.pdf

Geahča maid